Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3043)
All Articles published online
|
Aug 28, 2011 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mukherjee S. Betaine and nonalcoholic steatohepatitis: Back to the future? World J Gastroenterol 2011; 17(32): 3663-3664 [PMID: 21990946 DOI: 10.3748/wjg.v17.i32.3663] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i32/3663.htm |
| Number | Citing Articles |
| 1 |
Zoe Schofield, Michelle AC Reed, Philip N Newsome, David H Adams, Ulrich L Günther, Patricia F Lalor. Changes in human hepatic metabolism in steatosis and cirrhosis. World Journal of Gastroenterology 2017; 23(15): 2685-2695 doi: 10.3748/wjg.v23.i15.2685
|
| 2 |
Gard F T Svingen, Hall Schartum-Hansen, Eva R Pedersen, Per M Ueland, Grethe S Tell, Gunnar Mellgren, Pål R Njølstad, Reinhard Seifert, Elin Strand, Therese Karlsson, Ottar Nygård. Prospective Associations of Systemic and Urinary Choline Metabolites with Incident Type 2 Diabetes. Clinical Chemistry 2016; 62(5): 755 doi: 10.1373/clinchem.2015.250761
|
| 3 |
Mohammad Mehdi Ommati, Omid Farshad, Khadijeh Mousavi, Akram Jamshidzadeh, Mohammadreza Azmoon, Sirus Heidari, Negar Azarpira, Hossein Niknahad, Reza Heidari. Betaine supplementation mitigates intestinal damage and decreases serum bacterial endotoxin in cirrhotic rats. PharmaNutrition 2020; 12: 100179 doi: 10.1016/j.phanu.2020.100179
|
| 4 |
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
|
| 5 |
Icksoo Lee. Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (–)-Epicatechin, and Betaine. Cells 2021; 10(6): 1346 doi: 10.3390/cells10061346
|
| 6 |
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021; doi: 10.7759/cureus.20776
|
| 7 |
Christopher R. Day, Stephen A. Kempson. Betaine chemistry, roles, and potential use in liver disease. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(6): 1098 doi: 10.1016/j.bbagen.2016.02.001
|
| 8 |
Manan Bhatt, Angela Di Iacovo, Tiziana Romanazzi, Cristina Roseti, Elena Bossi. Betaine—The dark knight of the brain. Basic & Clinical Pharmacology & Toxicology 2023; 133(5): 485 doi: 10.1111/bcpt.13839
|
| 9 |
Manan Bhatt, Erika Lazzarin, Ana Sofia Alberto-Silva, Guido Domingo, Rocco Zerlotti, Ralph Gradisch, Andre Bazzone, Harald H. Sitte, Thomas Stockner, Elena Bossi. Unveiling the crucial role of betaine: modulation of GABA homeostasis via SLC6A1 transporter (GAT1). Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05309-w
|
| 10 |
Anna Del Prete, Antonella Scalera, Maddalena Diana Iadevaia, Agnese Miranda, Claudio Zulli, Laura Gaeta, Concetta Tuccillo, Alessandro Federico, Carmelina Loguercio. Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/837939
|